Visualitza per autor "DEAN, ANDREW"
Ara mostrant els elements 1-5 d 5
-
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Matulonis, Ursula; pignata, sandro; DEAN, ANDREW; denys, hannelore; Lorusso, Domenica; OAKNIN, ANA (American Society of Clinical Oncology, 2023-05-01) -
Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety
Oaknin Benzaquen, Ana Mazaltob; Oza, Amit M.; Lorusso, Domenica; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Wiley, 2021-10) -
Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma
Oza, Amit M.; Lorusso, Domenica; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (American Society of Clinical Oncology, 2020-10-20) -
Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer
Brendel, Karl; Bekaii-Saab, Tanios S; Boland, Patrick M; Dayyani, Farshid; Macarulla Mercadé, Teresa; Dean, Andrew (Wiley, 2021-12) -
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
Oza, Amit M.; Lorusso, Domenica; Oaknin Benzaquen, Ana Mazaltob; Dean, Andrew; Colombo, Nicoletta; Aghajanian, Carol (Elsevier, 2020-10-01)